Just Released
|
||
Federal Legislation Related to Medicaid and Opioids: What to Watch
With President Trump
having declared the opioid epidemic a public health emergency, both the House
and Senate are advancing legislation to address the crisis. A new issue brief from the Kaiser Family Foundation
summarizes current federal legislative proposals related to Medicaid’s role
in the opioid epidemic and identifies issues to watch as final legislation
takes shape.
The House has passed several bills culminating in
the Substance Use Disorder Prevention that Promotes Opioid Recovery and
Treatment (SUPPORT) for Patients and Communities Act. The Senate Finance
Committee has approved the Helping to End Addiction and Lessen (HEAL)
Substance Use Disorders Act, which is expected to be considered by the full
Senate later this year. Appendix tables detail the House SUPPORT Act, the
Senate HEAL Act, and other bills pending at the Senate and House committee
level as of late June, 2018
Any final legislation could affect state Medicaid
programs, SUD treatment providers, health plans, beneficiaries and other
stakeholders.
To see more of KFF’s work related to the opioid
epidemic visit our special resource page on this topic.
Filling
the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit
organization based in San Francisco, California.
|
||
|
||
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Monday, July 2, 2018
Federal Legislation Related to Medicaid and Opioids: What to Watch
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment